共 466 条
[11]
Godoy MC(2013)Crizotinib versus chemotherapy in advanced ALK-positive lung cancer N Engl J Med 368 2385-2394
[12]
Naidich DP(2012)Non–Small Cell Lung Cancer J Natl Compr Cancer Netw 10 1236-1271
[13]
Lee HY(2013)Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology J Mol Diagn 15 415-453
[14]
Lee KS(2012)Adenocarcinomas with Predominant Ground-Glass Opacity: Correlation of Morphology and Molecular Biomarkers Radiology 264 590-596
[15]
Travis WD(2009)Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread J Thorac Oncol 4 1490-1495
[16]
Brambilla E(2007)Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity Jpn J Clin Oncol 37 907-912
[17]
Noguchi M(2006)Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma J Thorac Oncol 1 413-416
[18]
Nicholson AG(2003)Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma Ann Thorac Surg 76 1828-1832
[19]
Geisinger KR(2009)The 7th Edition of TNM in Lung Cancer: what now? J Thorac Oncol 4 671-673
[20]
Yatabe Y(2012)Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer Lung Cancer 75 321-325